To further support the potential relevance of our findings to the cell types more related to neurodegeneration, we assessed the effect of ARH3 loss on the sensitivity of glioblastoma U251 cells to PARG and PARP inhibition. This evidence concerns the gene PARP1 and glioblastoma.